TheStreet.com  Apr 20  Comment 
NEW YORK (TheStreet) -- Shares of Genetic Technologies Limited  surged 27.66% to $5.40 in late morning trading Monday after the molecular diagnostics company announced that two new breast health centers will start to offer BREVAGenplus®....
Benzinga  Apr 20  Comment 
Genetic Technologies Limited (ADR) (NASDAQ: GENE) shares jumped 30.77 percent to $5.53 after the company reported additional breast health centres will begin offering BREVAGenplus. Tetralogic Pharmaceuticals Corp (NASDAQ: TLOG) rose 25.49...
Benzinga  Apr 20  Comment 
Genetic Technologies Limited (NASDAQ: GENE) is pleased to announce that a further two (2) new breast health centres will begin to offer BREVAGenplus to their at-risk patients in a systematic fashion. This is in addition to the six (6) breast...
GenEng News  Mar 26  Comment 
Ten biopharma companies have joined together to create the Genomics Expert Network for Enterprises (GENE) Consortium, which will oversee a year-long trial designed to integrate industry expertise into the 100,000 Genomes Project—the U.K.’s...
Benzinga  Jan 29  Comment 
Genetic Technologies Limited (NASDAQ: GENE) shares jumped 36.74% to $1.74. Genetic Technologies announced up to 6 new breast centres to begin offering BREVAGenplus. Harman International Industries, Incorporated (NYSE: HAR) shares rose 16.39% to...
Benzinga  Dec 17  Comment 
Molecular diagnostics company Genetic Technologies Limited (NASDAQ: GENE) announces that findings from a new research study show that adding a panel of 77 single-nucleotide polymorphisms ("SNPs") improves the predictive accuracy of four commonly...
The Australian  Nov 28  Comment 
HIGH-flying entrepreneur Mervyn Jacobson will spend a year in jail for illegally propping up Genetic Technologies’ share price.
The Australian  Nov 5  Comment 
FORMER Genetic Technologies chief Mervyn Jacobson is facing a prison term after being convicted of fraud and manipulating the stock market.
StreetInsider.com  Nov 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Agilent+Technologies+%28A%29+Reports+Dismissal+of+IP+Suit+Brought+by+Genetic+Technologies+%28GENE%29/9968080.html for the full story.

You may also be interested in articles related to GENETIC TECHNOLOGIES (GENE):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki